StockData
GE HealthCare Technologies Inc. logo

GE HealthCare Technologies Inc. (GEHC) stock

GEHCNasdaqX-Ray Apparatus & Tubes & Related Irradiation ApparatusFiscal year ends December 31
Financials through Q3 FY2026, quarter ended Sep 30, 2026Last filing: 10-Q on Oct 28, 2026Score 15/3011% below fair value
$83.66+1.82 (+2.22%)

Close on Nov 18, 2026Market cap $37.83BP/E 17.6Yield 0.17%

GE HealthCare Technologies operating income

Operating income is the profit from the core business after operating expenses such as R&D and selling costs, before interest and taxes.

GE HealthCare Technologies's operating income for the twelve months ending Sep 30, 2026 was $2.89B, up 5.4% year over year. For fiscal 2025 it was $2.76B, up 5.3% from the year before. The highest annual figure on record is $2.80B in fiscal 2021.

Annual operating income

PeriodPeriod endValueChange
FY2025Dec 31, 2025$2.76B+5.3%
FY2024Dec 31, 2024$2.63B+7.8%
FY2023Dec 31, 2023$2.44B-3.4%
FY2022Dec 31, 2022$2.52B-9.8%
FY2021Dec 31, 2021$2.80B–

Quarterly operating income

Change is against the same quarter a year earlier.

PeriodPeriod endValueChange
Q3 FY2026Sep 30, 2026$805.00M+23.3%
Q2 FY2026Jun 30, 2026$739.00M+13.0%
Q1 FY2026Mar 31, 2026$515.00M-18.1%
Q4 FY2025Dec 31, 2025$827.00M+3.2%
Q3 FY2025Sep 30, 2025$653.00M-3.4%
Q2 FY2025Jun 30, 2025$654.00M+7.6%
Q1 FY2025Mar 31, 2025$629.00M+16.5%
Q4 FY2024Dec 31, 2024$801.00M+16.3%
Q3 FY2024Sep 30, 2024$676.00M+9.6%
Q2 FY2024Jun 30, 2024$608.00M+6.7%
Q1 FY2024Mar 31, 2024$540.00M-3.4%
Q4 FY2023Dec 31, 2023$689.00M-11.3%
Q3 FY2023Sep 30, 2023$617.00M+2.0%
Q2 FY2023Jun 30, 2023$570.00M-9.7%
Q1 FY2023Mar 31, 2023$559.00M+9.8%
Q4 FY2022Dec 31, 2022$777.00M–
Q3 FY2022Sep 30, 2022$605.00M–
Q2 FY2022Jun 30, 2022$631.00M–
Q1 FY2022Mar 31, 2022$509.00M–

More GE HealthCare Technologies figures

See a number that looks wrong?